Clinical Trials

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio

Colorectal Cancer


LY2157299 for Metastatic Cancer and Advanced or Metastatic Pancreatic Cancer
A Phase 1b/2 Study With Gemcitabine and LY2157299 for Patients With Metastatic Cancer (Phase 1b) and Advanced or Metastatic Unresectable Pancreatic Cancer (Phase 2)

Investigator: Andrew Coveler, MD;   Conditions: Neoplasms, Neoplasm Metastasis, Pancreatic Cancer;    Status: Closed;   Study ID: NCT01373164

Chemotherapy or Chemotherapy + Radiation for Rectal Cancer Patients Undergoing Surgery (The PROSPECT Trial)
A Phase II/III Trial of Neoadjuvant FOLFOX, With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision

Investigator: Veena Shankaran, MD;   Conditions: Colorectal Cancer;    Status: Recruiting;   Study ID: NCT01515787